tert-Butyl ((2-azaspiro[3.5]nonan-7-yl)methyl)carbamate hydrochloride

Catalog No.: 
ACVTOI571
CAS No.: 
2832710-33-3
Molecular Formula: 
C14H27ClN2O2
Molecular Weight: 
290.83
tert-Butyl ((2-azaspiro[3.5]nonan-7-yl)methyl)carbamate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$478.00InquiryInquiry
250mg95%$638.00InquiryInquiry
500mg95%$1062.00InquiryInquiry
1g95%$1593.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((2-azaspiro[3.5]nonan-7-yl)methyl)carbamate hydrochloride
IUPAC Nametert-butyl ((2-azaspiro[3.5]nonan-7-yl)methyl)carbamate hydrochloride
Molecular FormulaC14H27ClN2O2
Molecular Weight290.83
SMILESO=C(OC(C)(C)C)NCC(CC1)CCC21CNC2.[H]Cl
InChI KeyAPOXIOCGQCNYFW-UHFFFAOYSA-N
SynonymF78250 | TERT-BUTYL N-(2-AZASPIRO[3.5]NONAN-7-YLMETHYL)CARBAMATE HYDROCHLORIDE | 2832710-33-3
CAS No.2832710-33-3
PubChem CID165430990

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVTOI571 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVTOI571 route product structure diagram
    ACVTOI5712832710-33-3
Inquiry

2. ACVTOI571 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVTOI571 route product structure diagram
    ACVTOI5712832710-33-3
Inquiry

3. ACVTOI571 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVTOI571 route product structure diagram
    ACVTOI5712832710-33-3
Inquiry

Comments (0)